Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - omega-3-acid ethyl esters 90, quantity: 1000 mg - capsule, soft - excipient ingredients: purified water; gelatin; glycerol; d-alpha-tocopherol - hypertriglyceridaemia: endogenous hypertriglyceridaemia as a supplement to diet when dietary measures alone are insufficient to produce an adequate response. treatment is indicated for the following types of dyslipidaemia (fredrickson classification) only: -type iv & v as monotherapy and with close monitoring of ldl-c levels. - type iib as add-on therapy to statins, when control of triglycerides with statins has been shown to be insufficient. patients with higher baseline levels of triglycerides are more likely to exhibit a better response to omacor. omacor is not indicated in exogenous hypertriglyceridaemia (type 1 hyperchylomicronaemia). there are insufficient data to support the use in patients with secondary endogenous hypertriglyceridaemia including patients with diabetes mellitus.

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

glenmark pharmaceuticals europe ltd - eicosapentaenoic acid; docosahexaenoic acid - oral capsule - 460mg ; 380mg

Filipīnas - angļu - FDA (Food And Drug Administration)

patriot pharmaceuticals corporation; distributor: patriot pharmaceuticals corporation - eicosapentaenoic acid (epa) ethyl ester , docosahexaenoic acid (dha)  ethyl ester - softgel capsule - 460 mg/380 mg

Īrija - angļu - HPRA (Health Products Regulatory Authority)

epax as - omega-3-acid ethyl esters 90 - capsules, soft - 1000 milligram

Austrālija - angļu - Department of Health (Therapeutic Goods Administration)

abbott australasia pty ltd - omega-3-acid ethyl esters 90 -

Malta - angļu - Medicines Authority

basf as p.o.box 420, n-1327 lysaker, norway - omega, acid ethyl, esters - soft capsule - omega-3-acid ethyl esters 90 1000 mg - lipid modifying agents

Amerikas Savienotās Valstis - angļu - NLM (National Library of Medicine)

sterling-knight pharmaceuticals, llc - omega-3-acid ethyl esters (unii: d87ygh4z0q) (omega-3 fatty acids - unii:71m78end5s), 12-hydroxyeicosapentaenoic acid, (12r)- (unii: 78p2zc128s) (12-hydroxyeicosapentaenoic acid, (12r)- - unii:78p2zc128s), 4,7,10,13,16,19-docosahexaenoic acid, (4e,7e,10e,13e,16e,19e)- (unii: zr7nx0z98x) (4,7,10,13,16,19-docosahexaenoic acid, (4e,7e,10e,13e,16e,19e)- - unii:zr7nx0z98x) - luvira is an orally administered prescription probiotic formulation for the clinical dietary management of suboptimal nutritional status in patients where advanced supplementation is required and nutritional supplementation in physiologically stressful conditions for maintenance of good health is needed.

Īrija - angļu - HPRA (Health Products Regulatory Authority)

basf as - omega-3-acid ethyl esters - capsule, soft - 1000 milligram(s) - other lipid modifying agents; omega-3-triglycerides incl. other esters and acids

Īrija - angļu - HPRA (Health Products Regulatory Authority)

pco manufacturing ltd. - omega-3-acid ethyl esters 90 - capsule, soft - 1000 milligram(s) - other lipid modifying agents; omega-3-triglycerides incl. other esters and acids

Īrija - angļu - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - omega-3-acid ethyl esters - capsule, soft - 1000 milligram(s) - other lipid modifying agents; omega-3-triglycerides incl. other esters and acids